Track topics on Twitter Track topics that are important to you
For optimal treatment in cancerology, clinicians need specific, precise, sensitive methods to quantify treatment response, monitor residual disease and detect early recurrence in patients. Residual ...
(MedPage Today) -- Knowing when to use the phone versus the portal is essential, says Rosemarie Nelson
Global CRO Icon has launched the Firecrest Patient Portal. This portal enables patients to view clinical trial information and is specifically designed to enhance the patients’ understanding of tre...
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the Firecrest Patient Porta...
The Joint Commission and the American Society for Healthcare Engineering (ASHE) have launched the new Physical Environment Portal to provide online resources and tools for hospitals to be compliant wi...
How common are portal vein obstructions, how do they develop, and how are they best treated? Alimentary Pharmacology & Therapeutics
Taking a page out of many insurers' books, Theranos is launching a new web portal to connect patients with primary care doctors.
Much has been made of the push to better engage patients, but little has been spent on examining exactly what patients want. Despite the requirements set by the EHR Incentive Program, simply deploying...
The Institution of Chemical Engineers (IChemE) has launched a portal for job seekers, helping process engineers find new opportunities and employers recruit top-class talent.
Portal biliopathy is a term to describe the spectrum of abnormalities of the entire biliary tract or gallbladder associated with portal hypertension. The most common cause of portal biliopathy is extr...
The aim of the present study was to assess the clinical efficiency of portal vein (PV) stenting when performed with preoperative percutaneous transhepatic portal vein embolization (PTPVE) in patients ...
To determine the pathogenesis of liver nodules, and lesions similar to obliterative portal venopathy, observed after portosystemic shunts or portal vein thrombosis in humans.
The compensatory increase in hepatic arterial flow with a decrease in portal venous flow is known as the hepatic arterial buffer response. In cirrhosis with elevated portal pressure, the vascular resi...
To investigate the feasibility of estimating the portal vein blood volume that flows into the intrahepatic volume (IHPVBV) in each cardiac cycle using non-contrast MR venography technique as a surroga...